By the Editors
The FDA has approved pretomanid for highly treatment-resistant pulmonary tuberculosis. The drug is approved for use in conjunction with bedaquiline and linezolid in adults with extensively drug-resistant, treatment-intolerant, or nonresponsive multidrug-resistant TB
No comments:
Post a Comment